Whilst the positive correlation of activities between IDO1 and IFN-γ is strong in colorectal cancers, for example, it is relatively weak in ovarian or kidney cancers such that they may show great IDO1 expression but less activity of IFN-γ. The gene discussed is IDO1; the disease is colorectal cancer.